Western Uranium & Vanadium Corp. - 10-Q Filing
Western Uranium & Vanadium Corp. reports Q3 2026 results with 71.7 million common shares outstanding as of November 16, 2026.
Tickers: $WSTRF
Read the full article at SEC EDGAR
Part of the story PharmaCyte Biotech Approves 1-for-19 Reverse Stock Split to Meet Nasdaq Compliance (5 articles)